Pharma enters into definitive agreements for $24M private placement of common stock and warrants A.

A suhagra 100mg price .P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants A.P. Pharma, Inc. , a specialty pharmaceutical firm, today announced that it has entered into definitive agreements with particular new and existing accredited traders providing for an exclusive placement of common share and warrants where the Company can receive $24 million in gross proceeds. The common stock and warrants are for sale in devices at a price of $0.15 per unit. Each unit consists of one talk about of common share and one warrant to purchase 0.5 additional shares of common stock at a price of $0.18 per share. About July 1 The transaction is likely to close on or, 2011, at the mercy of customary closing conditions.

Our strong development was driven by a good balance of existing customers expanding our part and new businesses requiring our global experience, said Suneet Walia, Chief and President Executive Officer of APCER Pharma Solutions, Inc., the group's US division. We will continue steadily to empower our teams to deliver high quality, cost-effective compliance while we expand our scope and size to meet up increased demand. APCER Pharma is the only drug safety specialty firm with in-house operations on three continents. Its 24×7 Integrated Response Center maintains regulatory cleverness and submits safety-related reviews on behalf of its clients in a lot more than 100 countries.